• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Holdings
© 2025 Longbridge|Disclaimer

Event Tracking

Dec7
Hengrui Medicine's 10 Products Included in the New National Health Insurance Drug List
03:50
Dec2
Hengrui Medicine Initiates Share Repurchase Plan
08:46
Hengrui Medicine's Remimazolam Trometamol Injection Marketing Authorization Application Accepted by NMPA
08:45
Dec1
GIC Private Limited Increases Stake in Hengrui Medicine to 23.03%
12:32
Nov28
Nomura Reiterates Buy Rating on WuXi AppTec, Raises Target Price to HKD132.8
03:55
Nov27
Hengrui Medicine Obtains Clinical Trial Approval Notices for Multiple Drugs
09:03